Neuropsychotropic Drug Therapy 2021 | Psychopharmacology for Depression During Pregnancy and Postpartum

Neuropsychotropic Drug Therapy 2021

Psychopharmacology for Depression During Pregnancy and Postpartum

On-Demand Program

Speaker

Amritha Bhat, MBBS, MD, MPH, Acting Assistant Professor, Psychiatry, School of Medicine, University of Washington, Seattle

Target Audience

Objectives for Learning Outcomes

At the conclusion of this activity, participants will be better able to:

1. Describe risks of untreated depression and anxiety during pregnancy and postpartum for mothers and children.
2. Discuss recent findings regarding risks of psychotropic medications during pregnancy and postpartum.
3. Discuss how recent findings affect informed consent discussions with patients.